In vivo light dosimetry for motexafin lutetium-mediated PDT of recurrent breast cancer

Lasers in Surgery and Medicine

Volumn 31, Issue 5, 2002, Pages 305-312

  Dimofte, Andreea ^a   Zhu, Timothy C ^a,b   Hahn, Stephen M ^a   Lustig, Robert A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Chest wall PDT; Diffuse reflectance; In vivo dosimetry; Light fluence rate

Indexed keywords

LUTETIUM TEXAPHYRIN;

ARTICLE; ATTENUATION; BREAST CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; DIFFUSE REFLECTANCE SPECTROSCOPY; DOSIMETRY; HUMAN; LIGHT IRRADIANCE; OPTICS; PHASE 2 CLINICAL TRIAL; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RECURRENT CANCER; THORAX WALL;

ADULT; BREAST; BREAST NEOPLASMS; FEMALE; HUMANS; LIGHT; METALLOPORPHYRINS; NEOPLASM RECURRENCE, LOCAL; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; RADIOMETRY; REPRODUCIBILITY OF RESULTS; SCATTERING, RADIATION; THORACIC WALL; TIME FACTORS;

EID: 0036917408     PISSN: 01968092     EISSN: None     Source Type: Journal    
DOI: 10.1002/lsm.10115     Document Type: Article

References (24)

1. Dougherty TJ, Gomer CJ, Henderson BW, Dori G, Kessel D, Korbelik M, Moan D, Peng Q. Photodynamic therapy. J Natl Cancer Inst 1998;90:889-901.
2. Katz A, Strom TA, Buchholz TA, Thames MD, Smith CD, Dhingran A, Mortobagyi G, Buzdar AU, Theriault R, Singletary SE, Meneese MD. Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: Implications for postoperative irradiation. J Clin Oncol 2000;18:2817-2827.
3. Dahlstrom KK, Andersson AP, Andersen M, Krag C. Wide local excision of recurrent breast cancer in the thoracic wall. Cancer 1993;72:774-777.
4. Della-Fiorentina SA, Harnett PR. Systemic therapy for breast cancer relapsing after chemotherapy and radiation for locally advanced disease. Proc Am Soc Clin Oncol 1997;16:A579 (abstract).
5. Halverson KJ, Perez CA, Kuske RR. Locoregional recurrence of breast cancer: A retrospective comparison of irradiation alone versus irradiation and systemic therapy. Am J Clin Oncol 1992;15:93-101.
6. Sperduto PW, DeLancy TF, Thoma G, Smith P, Dachowski LO, Russo A, Bonner R, Glatstein E. Photodynamic therapy for chest wall recurrence in breast cancer. Int J Radiat Oncol Biol Phys 1991;21:441-446.
7. Wyss P, Schwartz V, Dobler-Girdziunaite D, Hornung R, Walt H, Degen A, Fehr MK. Photodynamic therapy of locoregional breast cancer recurrences using a chlorin-type photosensitizer. Int J Cancer 2001;93:720-724.
8. Mang TS, Allison R, Hewson G, Snider N, Moskowitz R. A phase II/III clinical study of etiopurpurin (Purlytin)-induced photodynamic therapy for the treatment of recurrent cutaneous metastatic breast cancer. Cancer J Sci Am 1998;378-384.
9. Renschler MF, Yuen AR, Panella TJ, Wieman TO, Dougherty S, Esserman L, Panjehpour M, Taber SW, Fingar VM, Lowe E, Engel JS, Lum B, Woodbum K. Photodynamic therapy trials with lutetium texaphyrin (Lu-tex) in patients with locally recurrent breast cancer. Proc SPIE 1998;3247:35-39.
10. Vulcan TG, Zhu TC, Rodriguez CE, His RA, Fraker DL, Baas P, Murrer LH P, Star WM, Glatstein E, Yodh AG, Hahn SM. Comparison between isotropic and nonisotropic dosimetry systems during intraperitoneal photodynamic therapy. Lasers Surg Med 2000;26:292-301.
11. Tan IB, Oppelaar H, Ruevekamp MC, Veenhuizen RB, Timmers A, Stewart FA. The importance of in situ light dosimetry for photodynamic therapy of oral cavity tumors. Head Neck 1999;434-441.
12. Marijnissen JPA, Star WM, Zandt HJA, D'Hallewin MA, Baert L. In situ light dosimetry during whole bladder wall photodynamic therapy: Clinical results and experimental verification. Phys Med Biol 1993;38:567-582.
13. Woodburn KW, Fan Q, Kessel D, Luo Y, Yours SN. Photodynamic therapy of B16F10 murine melanoma with lutetium texaphyrin. J Invest Dermatol 1998;110:746-751.
14. Pandey RK. Recent advances in photodynamic therapy. Applied Optics Phthalocyanines 2000;4:368-373.
15. Baas P, Murrer LHP, Zoetmulder FAN, Stewart FA, Ris HB, van Zandwijk N, Rutgers E M. Photodynamics therapy as adjunctive in surgically treated pleural malignancies. Br J Cancer 1997;76:819-826.
16. Chen Q, Wilson BC, Shetty SD, Patterson MS, Cerny JC, Hetzel FW. Changes in vivo optical properties and light distributions in normal canine prostate during photodynamic therapy. Radiat Res 1997;147:86-91.
17. Jacques SL. Optics of light dosimetry for PDT in superficial lesions versus bulky tumors. Proc SPIE 2002;4612:59-68.
18. Marijnissen JPA, Star WM. Calibration of isotropic light dosimetry probes based on scattering bulbs in clear media. Phys Med Biol 1996;41:1191-1208.
19. Farrell J, Paterson MS, Wilson B. A diffusion theory model of spatially resolved, steady-state diffuse reflectance for the noninvasive determination of tissue optical properties in vivo. Med Phys 1992;19:879-883.
20. Groenhuis RAJ, Ferwerda HA, Bosch JJT. Scattering and absorption of turbid materials determined from reflection measurements. 1. Theory. App Opt 1983;22:2456-2462.
21. Groenhuis RAJ, Bosch JJT, Ferwerda HA. Scattering and absorption of turbid materials determined from reflection measurements. 2: Measuring method and calibration. App Opt 1983;22:2463-2467.
22. Jacques SL. Light distributions from point, line and plane sources for photochemical reactions and fluorescence in turbid biological tissues. Photochem Photobiol 1998;67:23-32.
23. Star WM. Light dosimetry in vivo. Phys Med Biol 1997;42:763-787.
24. Wilson BC, Jeeves WP, Lowe DM, Adam G. Light propagation in animal tissues in the wavelength range 375-825 nanometers. In: Doiron DR, Gomer CJ, editors. Porphyrin Localization and Treatment of Tumors. New York: Liss, Inc.; 1984. p 115-132.